- Report
- May 2024
- 134 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- June 2024
- 200 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- January 2022
- 60 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Report
- February 2024
- 180 Pages
Global
From €4764EUR$4,969USD£3,980GBP
Exanthema drugs are a type of immune disorder drug used to treat skin conditions such as rashes, hives, and eczema. These drugs work by suppressing the body's immune response, which can reduce inflammation and itching. They are typically prescribed for short-term use, as long-term use can lead to serious side effects. Common exanthema drugs include topical corticosteroids, topical calcineurin inhibitors, and oral antihistamines.
The exanthema drug market is highly competitive, with many companies offering a variety of products. Major players in the market include Pfizer, Novartis, Merck, and Sanofi. Other companies such as Mylan, Sun Pharmaceuticals, and Teva Pharmaceuticals also offer exanthema drugs. These companies are constantly innovating to develop new products and improve existing ones. Show Less Read more